Nkarta, Inc. Investment Income, Interest
Nkarta, Inc. (NKTX) reported Investment Income, Interest of $206.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2020-11-12
- Nkarta, Inc. investment income, interest for the quarter ending 2020-09-30 was $206.00K, a 83639.84% increase year-over-year.
- Nkarta, Inc. investment income, interest for the quarter ending 2020-06-30 was $27.18K, a 24.35% increase year-over-year.
- Nkarta, Inc. investment income, interest for the quarter ending 2019-09-30 was $246.00.
- Nkarta, Inc. investment income, interest for the quarter ending 2019-06-30 was $21.86K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2020-09-30 | $206.00K 10-Q · filed 2020-11-12 | $233.18K derived: sum of 2 quarters · filed 2020-11-12 | $358.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $27.18K 10-Q · filed 2020-08-20 | $151.79K 10-Q · filed 2020-08-20 | |
| 2019-09-30 | $246.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $22.10K derived: sum of 2 quarters · filed 2020-11-12 | $60.00K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $21.86K 10-Q · filed 2020-08-20 | $59.75K 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |